Latest Statin Stories

April Flowers for redOrbit.com - Your Universe Online The good, the bad, and the ugly might sound like the title of a spaghetti western, but in reality it is the three types of cholesterol in your body. A new study from the University of Copenhagen shows that ischemic heart disease – is three times higher in individuals with high levels of the "ugly" kind of cholesterol. The study, published in the Journal of the American College of Cardiology, used data from 73,000 Danes to shed...

This study is a Phase 1, Placebo-Controlled, Randomized Trial to Assess the Safety and Tolerability of a New Drug in Obese Hyperlipidemic Adults with or without Type 2 Diabetes DeLand, Florida (PRWEB) January 21, 2013 **Avail Clinical Research is now enrolling for a Type 2 Diabetes Clinical Trial in Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. BACKGROUND & RATIONALE Type 2 diabetes (T2DM) is one of the largest medical burdens in the...

redOrbit Staff & Wire Reports – Your Universe Online New Jersey-based pharmaceutical company Merck is telling doctors to stop prescribing the cholesterol drug Tredaptive following a study that casts doubt on the medication’s efficacy and safety. Tredaptive, which has not yet been approved in the US, is currently sold in more than three dozen countries worldwide, according to the Associated Press. In addition to putting a halt to prescriptions, Merck is also advising patients to...

PLYMOUTH, Mich., Jan 7, 2013 /PRNewswire/ -- Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo. ETC-1002 therapy was also associated with improvements in control of additional cardiometabolic risk factors in this high-risk,...

PLYMOUTH, Mich., Jan 4, 2013 /PRNewswire/ -- Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced that Tim Mayleben has been named president and CEO of the company. Roger Newton, Ph.D., FAHA, who is the founder of Esperion and has been serving as its president and CEO, will become executive chairman and chief scientific officer. Most recently, Mr. Mayleben was president and CEO at Aastrom...

Voices Against Brain Cancer replies to an article published by NBC News regarding a new study which claims that cancer patients who took the drug were less likely to pass away than those who did not. New York, NY (PRWEB) December 08, 2012 On December 8, Voices Against Brain Cancer (VABC) releases a statement in reaction to the results of a new study on taking a cholesterol lowering drug that reduces the death risk in cancer patients. According to an article on NBC News, “the patients...

Connie K. Ho for redOrbit.com – Your Universe Online New Delhi-based Ranbaxy Laboratories recently announced that they would stop production of Atorvastatin, a product similar to Pfizer Inc.’s Lipitor that focuses on fighting high cholesterol. The company’s decision was prompted by a recent recall by the U.S. Food and Drug Administration (FDA). The voluntary recall covers Atorvastatin tablets at 10mg, 20mg, and 40mg strengths. The tablets were recalled due to the possibility of...

Connie K. Ho for redOrbit.com – Your Universe Online A new study published in the Canadian Medical Association Journal shows that, while there is a rise in the number of prescription drugs that result in negative effects due to interactions with grapefruit, few physicians are aware of these consequences. The article was completed by a group of researchers who discovered the interactions among grapefruit and prescription drugs over 20 years ago. By summarizing the evidence available,...

NEW YORK, Nov. 21, 2012 /PRNewswire/ -- As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck's asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. Top Five Drugs by Sales, Q3 2012 Drug Name Sales ($000) % Change (previous quarter) --- ------- Nexium...

New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The research will be presented in two presentations at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). The meeting will be held Nov. 9-14, in Washington D.C. "What we have shown is that...